To further evaluate the clinical impact of CHIP on RA phenotypes and outcomes, we collected DNA samples from four distinct RA patient cohorts of newly diagnosed, previously untreated, patients with RA without hematologic malignancies (table S8). Here, STUB1 is linked to rheumatoid arthritis.